R
REJOIN Medical
Specializes in sports medicine and minimally invasive orthopedic solutions for global healthcare professionals
About REJOIN Medical
Rejoin Medical, established in 2009 and rebranded in 2014, specializes in providing minimally invasive orthopedic solutions tailored for sports medicine. Initially an OEM supplier for leading orthopedic companies, Rejoin Medical has grown to support healthcare professionals globally, reaching surgeons across five continents. The company operates in the medical device market, focusing on innovative orthopedic products that facilitate less invasive surgical procedures. Rejoin Medical's business model revolves around the development, manufacturing, and distribution of these specialized medical devices. Revenue is generated through direct sales to healthcare providers and partnerships with global distributors. The company serves a diverse clientele, including hospitals, clinics, and specialized orthopedic surgeons, aiming to enhance patient outcomes and surgical efficiency.
Source: Dealroom company dataNews
Open roles
REJOIN Medical in the Hangzhou ecosystem
The REJOIN Medical office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A2 investors entered at this stage
Vertex Ventures ChinaAddor Capital
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about REJOIN Medical on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See REJOIN Medical on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
